NCT05042154View on ClinicalTrials.gov

Prevalence of OSA in COPD and the Clinical Impact of OSA Diagnosis and Treatment

NAUnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

January 1, 2023

Conditions
Prevalence of OSA in Patients Hospitalized With COPD Exacerbation
Interventions
DEVICE

WatchPAT

The WatchPAT One can detect the presence of OSA based on measurement of peripheral arterial tone (PAT), pulse rate, oxygen saturation, actigraphy, snoring, and body position.

Sponsors
All Listed Sponsors
lead

Atlantic Health System

OTHER